Test Price
1,800 AED✅ Home Collection Available
Spino‑Bulbar Muscular Atrophy (SBMA) Genetic Test in UAE | 1,800 AED
Executive Summary & Core Metrics
Executive Summary: The SBMA genetic test utilizes fluorescent capillary electrophoresis fragment analysis to precisely quantify CAG repeat expansions in the androgen receptor (AR) gene, delivering definitive diagnostic clarity for Kennedy disease. Our ISO 15189:2022 accredited laboratory achieves 99.9% analytical sensitivity. We provide VIP mobile phlebotomy and temperature-controlled cold-chain home collection, direct insurance verification, and post-test clinical guidance by a board-certified Consultant Medical Geneticist.
99.9% Diagnostic Sensitivity via ISO 15189:2022 accredited processing and dual-geneticist validation.
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection. Available daily from 8 AM to 11 PM.
Telephonic post-test clinical guidance from a Consultant Medical Geneticist to interpret results in your clinical context.
📞 Insurance & Billing: Direct verification via WhatsApp +971 54 548 8731. Direct insurance billing supported for most UAE health networks.
Test Overview & Methodology
The SBMA genetic test precisely identifies the abnormal expansion of CAG repeats in the androgen receptor (AR) gene, confirming Kennedy disease – a progressive X-linked neuromuscular disorder. Our ISO 15189:2022 accredited laboratory delivers a definitive result within 5 working days using fluorescent capillary electrophoresis fragment analysis, enabling early intervention and cascade family screening.
| Feature | Our ISO 15189:2022 Test | Standard Hospital PCR |
|---|---|---|
| Precision | 99.9% Analytical Sensitivity | ~95% |
| Methodology | Fluorescent CE Fragment Analysis | Conventional gel-based PCR |
| Turnaround | 5 Working Days (Report by Saturday) | 7–10 Days |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I always correlate SBMA genetic results with a complete neurological examination and three-generation family pedigree. This test provides definitive diagnostic clarity but must not replace ongoing multidisciplinary care. Patients should never discontinue prescribed therapies without consulting their treating physician. If you or a family member develops sudden dysphagia, aspiration, or acute respiratory difficulty, seek emergency medical care immediately.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
🚨 Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: This test is not intended for emergency diagnosis and does not substitute for a complete clinical evaluation by a neurologist. Pre-test genetic counseling is mandatory.
- When to seek immediate help: Rapidly progressive dysphagia, unexplained weight loss, aspiration pneumonia, acute respiratory failure, or new-onset chest pain with severe limb weakness.
- Collection Safety: Home phlebotomy is performed exclusively by a DHA-licensed nurse. Samples are refrigerated at 2–8°C and never frozen. Collection should be rescheduled if the patient has an active fever or a known bleeding disorder.
Patient FAQ & Clinical Guidance
1. What is the SBMA genetic test and how accurate is it?
The SBMA genetic test detects an abnormal CAG trinucleotide repeat expansion in the androgen receptor (AR) gene with 99.9% analytical sensitivity, providing a definitive molecular diagnosis of Kennedy disease (Spinal and Bulbar Muscular Atrophy). This gold-standard assay utilizes capillary electrophoresis to precisely quantify the repeat number, guiding prognosis, and informing family planning decisions.
2. How is the sample collected and what preparation is required?
A 4 mL peripheral whole blood sample is collected in a lavender-top EDTA tube. The sample is maintained under strict temperature-controlled cold chain (2–8°C) and transported directly to our ISO 15189:2022 accredited laboratory. Patients must complete the mandatory Genomics Clinical Information Requisition Form (Form 20) to ensure accurate clinical correlation and interpretation.
3. When will results be ready and how are they delivered?
If the sample arrives at our laboratory before Tuesday at 11:00 AM, the final clinical report is issued by the following Saturday. Results are delivered via encrypted, HIPAA-compliant email and can be reviewed in a complimentary tele-consultation with our Consultant Medical Geneticist to discuss clinical implications.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework: All clinical and laboratory procedures at DNA Labs UAE strictly comply with Federal Decree-Law No. 4 of 2016 on Medical Liability for patient safety and informed consent. Patient data is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our DHA-licensed facility (License No. 1143) adheres to the highest standards of clinical confidentiality and data security.
Clinical & Logistical Metadata
| Test Name | Spino‑Bulbar Muscular Atrophy (SBMA) Genetic Test |
| Price (AED) | 1,800 AED |
| Turnaround Time | 5 Working Days |
| Sample Type / Matrix | Whole Blood (EDTA) |
| Methodology Used | Fluorescent CE Fragment Analysis |
| ICD-10-CM Code | G12.21 |
| LOINC Code | 21666-9 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians